Navigation Links
OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
Date:3/4/2013

Boulder, Colo. (PRWEB) March 04, 2013

Bio-based chemicals and fuels producer OPX Biotechnologies Inc. (OPXBIO) is being recognized as an Energy Innovation Pioneer at this week’s annual IHS CERAWeek conference in Houston – an honor that further signals the increasing role that bio-based producers can play in the global energy and chemical industries.

The annual Energy Innovation Pioneers program recognizes companies for their “potential to transform the energy future,” a goal that perfectly mirrors OPXBIO’s objective to transform the business of chemistry, according to president and CEO Charles R. (Chas) Eggert. With volatile and escalating petroleum prices, increasing regulatory constraints and growing consumer demands for more-sustainable products, OPXBIO can help existing petroleum-based manufacturers adopt new bio-based technology to successfully meet these challenges.

“Many conference attendees represent well-established, major oil & gas players, but the fact that a bio-based start-up like OPXBIO is also invited shows the industry recognizes the opportunity for new economic bio-processes to make chemicals and fuels,” Eggert said. “Today’s petroleum-based manufacturers are constantly striving for more-efficient process technology. Our process improvements use the rapid advancements in biotechnology and are accomplished using living cells engineered to perform as efficient, microscopic factories."

The Energy Innovation Pioneers program is held annually in conjunction with IHS CERAWeek, which is being held March 4-8 at the Hilton Americas-Houston. This year’s Energy Innovation Pi-oneers were selected based on creativity, plan feasibility, technology scalability and leadership team. The program recognized OPXBIO for developing bio-based processes that can use a variety of feedstocks to create renewable chemicals and fuels used in everything from consumer products to jet fuel.

OPXBIO, for example, is partnering with The Dow Chemical Co. to bring BioAcrylic – a direct and more-sustainable replacement for petro-based acrylic acid – into the $10-billion acrylic acid mar-ket for use in consumer products such as diapers, detergents, paints and adhesives. OPXBIO has also demonstrated lab-scale production of its second product – fatty acid from syngas for chemical and fuel applications – in a project that is supported by an award from the U.S. Department of Energy.

Eggert will present an overview of OPXBIO during an Energy Innovation Pioneers breakfast session on Tuesday, March 5 at 7:30 a.m., and again that same day at the conference’s Innovation Pioneer Showcase at 3:30 p.m.

About OPXBIO
OPX Biotechnologies (OPXBIO) is a leader in sustainably transforming the business of chemistry. As the "Good Chemistry" company, OPXBIO provides more sustainable value to customers by applying its proprietary EDGE ™ (Efficiency Directed Genome Engineering) technology to produce economic, bio-based chemicals that directly replace existing petroleum-based products. OPXBIO's EDGE is versatile and enables faster, more efficient development of bioprocesses using a variety of feedstocks. Founded in 2007, OPXBIO is financed by leading venture capital investors, and employs 65 people in Boulder, Colo.

For more information, visit http://www.opxbio.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10492128.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Leading Scientists to Debate Views on Rejuvenation Biotechnologies
2. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
3. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
4. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Webcor Builders Selected as the General Contractor for First Phase of LA BioMeds New Campus Master Plan
7. KGI Selected to Administer PSM Affiliation Process
8. Conflict of Interest Management System Selected by Via Christi Health
9. invivodata President Selected as Finalist for Ernst & Young Entrepreneur of the Year Award
10. Reno Efficient Sustainable Practices Selected to Provide Water and Energy Conservation Services To the County of San Diego
11. Companies Selected to Present at AdvaMed 2012 Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... Reichert Technologies, ... continues today to pursue the highest level of accuracy and quality with the ... Refractometer and the AR5 Refractometer. Accurate, reliable and tough enough for the ...
(Date:2/11/2016)... ... , ... Global Stem Cells Group, has announced ... new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, focusing ... The new GSCG clinic is headed by four prominent Ecuadorian physicians, including Pablo ...
(Date:2/10/2016)... 10, 2016 Early-career researchers from ... Peru , Uganda and Yemen ... health and nutrition   Indonesia , ... and Yemen are being honored for their ... are also celebrated for mentoring young women scientists who are pursuing careers ...
(Date:2/10/2016)... Feb. 10, 2016 NX Prenatal Inc., a ... NeXosome® technology for early warning of adverse pregnancy ... recent study by Dr. Thomas McElrath ... Maternal Fetal Medicine,s (SMFM) annual meeting held in ... , 2016.  The presentation reported initial positive top-line ...
Breaking Biology Technology:
(Date:2/9/2016)... , Feb. 9, 2016 Vigilant Solutions announces today ... reader (LPR) to develop a lead in a difficult homicide ... LPR data to locate the suspect vehicle. Due to the ... case have been omitted at the agency,s request. ... agency explains, "Our victim was found deceased at an intersection ...
(Date:2/3/2016)... -- --> --> ... Identification System Market by Component (Hardware and Software), Search ... Government, Healthcare, and Transportation) and Geography - Global Forecast ... to be worth USD 8.49 Billion by 2020 at ... The transformation and technology evolution from the manual process ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
Breaking Biology News(10 mins):